BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21868018)

  • 1. Genetic variants of the monocyte chemoattractant protein-1 gene and its receptor CCR2 and risk of coronary artery disease: a meta-analysis.
    Wang Y; Zhang W; Li S; Song W; Chen J; Hui R
    Atherosclerosis; 2011 Nov; 219(1):224-30. PubMed ID: 21868018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of cancer: a meta-analysis.
    Cho YA; Kim J
    Cytokine; 2013 Oct; 64(1):213-20. PubMed ID: 23876399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of MCP-1 and CCR-2 gene polymorphisms on coronary artery disease susceptibility.
    Lin HL; Ueng KC; Hsieh YS; Chiang WL; Yang SF; Chu SC
    Mol Biol Rep; 2012 Sep; 39(9):9023-30. PubMed ID: 22752804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of MCP-1 and CCR2 polymorphisms with the risk of late acute rejection after renal transplantation in Korean patients.
    Kang SW; Park SJ; Kim YW; Kim YH; Sohn HS; Yoon YC; Joo H; Jeong KH; Lee SH; Lee TW; Ihm CG
    Int J Immunogenet; 2008 Feb; 35(1):25-31. PubMed ID: 18186797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR2-64I is a risk factor for development of bladder cancer.
    Narter KF; Agachan B; Sozen S; Cincin ZB; Isbir T
    Genet Mol Res; 2010 Apr; 9(2):685-92. PubMed ID: 20449800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of monocyte chemotactic protein-1 and CC chemokine receptor 2 gene variants with chronic obstructive pulmonary disease.
    Bai J; Song H; Cai C; Zhang M; Xu S; Tan J
    DNA Cell Biol; 2012 Jun; 31(6):1058-63. PubMed ID: 22276574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma.
    Yeh CB; Tsai HT; Chen YC; Kuo WH; Chen TY; Hsieh YH; Chou MC; Yang SF
    J Surg Oncol; 2010 Sep; 102(3):264-70. PubMed ID: 20740585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CCL2 and CCR2 gene variants with endometrial cancer in Turkish women.
    Attar R; Agachan B; Kuran SB; Cacina C; Sozen S; Yurdum LM; Attar E; Isbir T
    In Vivo; 2010; 24(2):243-8. PubMed ID: 20364004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCP-1 and CCR2 gene variants in oral squamous cell carcinoma.
    Bektas-Kayhan K; Unur M; Boy-Metin Z; Cakmakoglu B
    Oral Dis; 2012 Jan; 18(1):55-9. PubMed ID: 21883707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of Parkinson's disease.
    Wang Y; Zhou M; Wang Y; Jiang D; Deng X
    J Neural Transm (Vienna); 2019 Nov; 126(11):1465-1470. PubMed ID: 31471711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis in patients infected with HIV is influenced by a mutant monocyte chemoattractant protein-1 allele.
    Alonso-Villaverde C; Coll B; Parra S; Montero M; Calvo N; Tous M; Joven J; Masana L
    Circulation; 2004 Oct; 110(15):2204-9. PubMed ID: 15466648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of genetic effects of polymorphisms in the MCP-1 and CCR2 genes on MI in the Icelandic population.
    Bjarnadottir K; Eiriksdottir G; Aspelund T; Gudnason V
    Atherosclerosis; 2006 Oct; 188(2):341-6. PubMed ID: 16356504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
    Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
    Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MCP-1 and CCR2 gene variants and the risk for osteoporosis and osteopenia.
    Eraltan H; Cacina C; Kahraman OT; Kurt O; Aydogan HY; Uyar M; Can A; Cakmakoğlu B
    Genet Test Mol Biomarkers; 2012 Apr; 16(4):229-33. PubMed ID: 22081934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of CCR2 polymorphisms with the number of closed coronary artery vessels in coronary artery disease.
    Cha SH; Lee JK; Lee JY; Kim HT; Ryu HJ; Han BG; Kim JW; Oh B; Kimm K; Shin HD; Park BL; Park S; Park HY; Jang Y
    Clin Chim Acta; 2007 Jul; 382(1-2):129-33. PubMed ID: 17482150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCP-1 and CCR2 gene polymorphisms in Czech patients with allergic disorders.
    Holla LI; Mrazek F; Petrek M
    Int J Immunogenet; 2009 Feb; 36(1):69-72. PubMed ID: 19055601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis.
    Nyquist PA; Winkler CA; McKenzie LM; Yanek LR; Becker LC; Becker DM
    Cerebrovasc Dis; 2009; 28(2):124-30. PubMed ID: 19506371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients.
    Szalai C; Duba J; Prohászka Z; Kalina A ; Szabó T; Nagy B; Horváth L; Császár A
    Atherosclerosis; 2001 Sep; 158(1):233-9. PubMed ID: 11500196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of monocyte chemotactic protein-1 and CC chemokine receptor 2 gene variants with preeclampsia.
    Agachan B; Attar R; Isbilen E; Aydogan HY; Sozen S; Gurdol F; Isbir T
    J Interferon Cytokine Res; 2010 Sep; 30(9):673-6. PubMed ID: 20726788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region.
    Gilbert J; Lekstrom-Himes J; Donaldson D; Lee Y; Hu M; Xu J; Wyant T; Davidson M;
    Am J Cardiol; 2011 Mar; 107(6):906-11. PubMed ID: 21247529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.